Patent Term Extension Application for INLURIYO (imlunestrant), Patent No. 10,654,866 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-1004

Patent Term Extension Application for INLURIYO (imlunestrant), Patent No. 10,654,866

Documents

Comments

Description

OPEN

Comment Period OpensFeb 2, 2026

Type	Title	Posted	Comments	Status
Other	Letter to U. S. Patent and Trademark Office	Apr 21, 2026	--

CDER

Patent Term Extension Application

Eli Lilly and Company

INLURIYO (imlunestrant)

Patent No. 10,654,866

OPEN